Cognition during active methamphetamine use versus remission
- PMID: 34612792
- PMCID: PMC8979254
- DOI: 10.1080/13803395.2021.1976734
Cognition during active methamphetamine use versus remission
Abstract
Objective: To evaluate whether cognitive performance in adults with active methamphetamine use (MA-ACT) differs from cognitive performance in adults in remission from MA use disorder (MA-REM) and adults without a history of substance use disorder (CTLs).
Method: MA-ACT (n = 36), MA-REM (n = 48), and CTLs (n = 62) completed the Neuropsychological Assessment Battery (NAB).
Results: The MA-ACT group did not perform significantly worse than CTLs on any NAB Index. The MA-REM group performed significantly (p < 0.050) worse than CTLs on the NAB Memory Index. The MA-ACT group performed significantly better than CTLs and the MA-REM group on the Executive Functions Index.
Conclusions: Some cognitive deficits are apparent during remission from MA use, but not during active use; this may result in clinical challenges for adults attempting to maintain recovery and continue with treatment.
Keywords: Cognition; addiction; dependence; neuropsychological; stimulant; substance use disorder.
References
-
- APA. (2000). Diagnostic and statistical manual for mental disorders (Fourth Edition, Text Revision ed.). Washington, DC: American Psychiatric Association.
-
- APA. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Washington, D.C.: American Psychiatric Association.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical